Medicare Enrolled

Dr. Susan Blue, M.D.

Optician · Fort Worth, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1001 WASHINGTON AVE, Fort Worth, TX 76104
8173347922
In practice since 2005 (20 years)
NPI: 1578540431 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Blue from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blue? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Blue

Dr. Susan Blue is an optician specialist in Fort Worth, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Blue performed 648 Medicare services across 534 unique beneficiaries.

Between the years covered by Open Payments, Dr. Blue received a total of $18,737 from 56 pharmaceutical and/or device companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Blue is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 648 Medicare services $18,737 industry payments

Medicare Practice Summary

Medicare Utilization ↗
648
Medicare services
Bottom 39% in TX for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
534
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 261 $86 $213
Office visit, established patient, complex (40-54 min) 116 $117 $286
Office visit, established patient (20-29 min) 84 $66 $144
New patient office visit, complex (60-74 min) 70 $165 $409
New patient office visit (45-59 min) 39 $116 $328
Needle measurement of electrical activity in arm or leg muscles, complete study 27 $75 $182
EEG, extended monitoring 22 $345 $799
Nerve conduction, 7-8 studies 16 $129 $368
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic 13 $11 $29
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,737
Total received (2018-2024)
Avg $2,677/year across 7 years
Top 10% in TX for optician
56
Companies
387
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,479 (55.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,257 (44.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$258
2023
$1,471
2022
$1,327
2021
$1,366
2020
$1,620
2019
$8,977
2018
$3,719

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$11,147
Biogen, Inc.
$851
GENZYME CORPORATION
$762
Teva Pharmaceuticals USA, Inc.
$735
Amgen Inc.
$476
Novartis Pharmaceuticals Corporation
$414
UCB, Inc.
$407
Lilly USA, LLC
$284
AbbVie Inc.
$244
Adamas Pharmaceuticals, Inc.
$244
Sumitomo Pharma America, Inc.
$210
ABBVIE INC.
$203
Supernus Pharmaceuticals, Inc.
$195
Amneal Pharmaceuticals LLC
$184
Acorda Therapeutics, Inc
$177
Biohaven Pharmaceuticals, Inc.
$174
Grifols USA, LLC
$168
Celgene Corporation
$161
PFIZER INC.
$117
Jazz Pharmaceuticals Inc.
$113
Eisai Inc.
$98
SK Life Science, Inc.
$96
Genentech USA, Inc.
$92
Neurelis, Inc.
$77
MITSUBISHI TANABE PHARMA AMERICA, INC.
$77
ARGENX US, INC.
$72
Horizon Therapeutics plc
$71
Janssen Pharmaceuticals, Inc
$67
BANNER LIFE SCIENCES, LLC
$62
ACADIA Pharmaceuticals Inc
$61
MDD US Operations, LLC
$57
Impax Laboratories, Inc.
$56
Banner Life Sciences, LLC
$46
Abbott Laboratories
$40
Neurocrine Biosciences, Inc.
$38
Allergan Inc.
$37
Kyowa Kirin, Inc.
$35
Avion Pharmaceuticals
$35
Allergan, Inc.
$31
Mitsubishi Tanabe Pharma America, Inc.
$29
Aucta Pharmaceuticals, Inc.
$29
Lundbeck LLC
$27
Vertical Pharmaceuticals, LLC
$27
UPSHER-SMITH LABORATORIES LLC
$23
AbbVie, Inc.
$19
Mallinckrodt LLC
$19
Upsher-Smith Laboratories LLC
$18
Avanir Pharmaceuticals, Inc.
$17
Zyla Life Sciences, Inc.
$17
NOVARTIS PHARMACEUTICALS CORPORATION
$16
Corium, LLC
$16
Currax Pharmaceuticals LLC
$14
Medtronic USA, Inc.
$14
Ipsen Biopharmaceuticals, Inc
$14
CSL Behring
$11
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 68.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · BAFIERTAM · Briviact · CONTRAVE · COPAXONE · DUOPA · DYSPORT · Dhivy · Duopa · EMGALITY · Fycompa · GOCOVRI · Gamunex-C · Gocovri · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · LEADPOINT · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Motpoly XR · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OSMOLEX ER · OXTELLAR XR · PANZYGA · Ponvory · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SPRIX · SUNOSI · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VUMERITY · VYVGART · VYVGART HYTRULO · Vimpat · ZEMBRACE SYMTOUCH · ZEPOSIA · ZINBRYTA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for optician in TX.

Equivalent to $2,891 per 100 Medicare services performed
Looking for an optician specialist in Fort Worth?
Compare opticians in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
188
Per 100K population
8.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Blue is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Blue experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Blue performed 261 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Blue receive payments from pharmaceutical companies?
Yes. Dr. Blue received a total of $18,737 from 56 companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Blue's costs compare to other opticians in Fort Worth?
Dr. Blue's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Blue) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →